Mitochondrial epigenetics in bone remodeling during hyperhomocysteinemia

Molecular and Cellular Biochemistry

Volumn 395, Issue 1-2, 2014, Pages 89-98

  Kalani, Anuradha ^a   Kamat, Pradip K ^a   Voor, Michael J ^a   Tyagi, Suresh C ^a   Tyagi, Neetu ^a  

^a University of Louisville School of Medicine   (United States)

Author keywords

Bone; DNA methylation; Epigenetics; Homocysteine; Mitochondria

Indexed keywords

HISTONE; HOMOCYSTEINE; MICRORNA; TRANSCRIPTOME;

BONE METABOLISM; BONE REMODELING; CPG ISLAND; DISEASE SEVERITY; DISORDERS OF MITOCHONDRIAL FUNCTIONS; DNA METHYLATION; EPIGENETICS; HISTONE MODIFICATION; HOMOCYSTINURIA; HUMAN; HYPERHOMOCYSTEINEMIA; MITOCHONDRIAL DYNAMICS; NONHUMAN; REVIEW; SKELETON MALFORMATION; ANIMAL; GENETIC EPIGENESIS; GENETICS; MITOCHONDRIAL GENOME; MITOCHONDRION; PATHOLOGY;

VASCONCELLEA CANDICANS;

ANIMALS; BONE REMODELING; EPIGENESIS, GENETIC; GENOME, MITOCHONDRIAL; HUMANS; HYPERHOMOCYSTEINEMIA; MITOCHONDRIA;

EID: 84906320235     PISSN: 03008177     EISSN: 15734919     Source Type: Journal    
DOI: 10.1007/s11010-014-2114-3     Document Type: Review

References (85)

1. Holstein JH, Herrmann M, Splett C, Herrmann W, Garcia P, Histing T, Klein M, Kurz K, Siebel T, Pohlemann T, Menger MD (2011) High bone concentrations of homocysteine are associated with altered bone morphology in humans. Br J Nutr 106:378-382. doi:10.1017/S0007114511000304
2. Kuroda T, Tanaka S, Saito M, Shiraki Y, Shiraki M (2013) Plasma level of homocysteine associated with severe vertebral fracture in postmenopausal women. Calcif Tissue Int 93:269-275. doi:10.1007/s00223-013-9754-2
3. Yang J, Hu X, Zhang Q, Cao H, Wang J, Liu B (2012) Homocysteine level and risk of fracture: a meta-analysis and systematic review. Bone 51:376-382. doi:10.1016/j.bone.2012.05.024
4. Papiha SS, Rathod H, Briceno I, Pooley J, Datta HK (1998) Age related somatic mitochondrial DNA deletions in bone. J Clin Pathol 51:117-120 (Pubitemid 28140724)
5. Varanasi SS, Francis RM, Berger CE, Papiha SS, Datta HK (1999) Mitochondrial DNA deletion associated oxidative stress and severe male osteoporosis. Osteoporos Int 10:143-149 (Pubitemid 29462203)
6. Byun HM, Baccarelli AA (2014) Environmental exposure and mitochondrial epigenetics: study design and analytical challenges. Hum Genet 133:247-257. doi:10.1007/s00439-013-1417-x
7. Choi YS, Hoon JJ, Min HK, Jung HJ, Hwang D, Lee SW, Kim PY (2011) Shot-gun proteomic analysis of mitochondrial D-loop DNA binding proteins: identification of mitochondrial histones. Mol BioSyst 7:1523-1536. doi:10.1039/c0mb00277a
8. Kraus JP, Janosik M, Kozich V, Mandell R, Shih V, Sperandeo MP, Sebastio G, de FR, Andria G, Kluijtmans LA, Blom H, Boers GH, Gordon RB, Kamoun P, Tsai MY, Kruger WD, Koch HG, Ohura T, Gaustadnes M (1999) Cystathionine beta-synthase mutations in homocystinuria. Hum Mutat 13:362-375. doi:10.1002/(SICI)1098- 1004(1999)13:5〈362:AID-HUMU4〉3.0.CO;2-K
9. Brenton DP (1977) Skeletal abnormalities in homocystinuria. Postgrad Med J 53:488-494
10. Herrmann M, Widmann T, Herrmann W (2005) Homocysteine - a newly recognised risk factor for osteoporosis. Clin Chem Lab Med 43:1111-1117. doi:10.1515/CCLM.2005.194 (Pubitemid 41581970)
11. Schedewie H, Willich E, Grobe H, Schmidt H, Muller KM (1973) Skeletal findings in homocystinuria: a collaborative study. Pediatr Radiol 1:12-23
12. Lim JS, Lee DH (2013) Changes in bone mineral density and body composition of children with well-controlled homocystinuria caused by CBS deficiency. Osteoporos Int 24:2535-2538. doi:10.1007/s00198-013-2351-4
13. Enneman AW, van d V, de JR, Heil SG, Stolk L, Hofman A, Rivadeneira F, Zillikens MC, Uitterlinden AG, van Meurs JB (2012) The association between plasma homocysteine levels, methylation capacity and incident osteoporotic fractures. Bone 50:1401-1405. doi:10.1016/j.bone.2012.03.013
14. Herrmann M, Umanskaya N, Wildemann B, Colaianni G, Widmann T, Zallone A, Herrmann W (2008) Stimulation of osteoblast activity by homocysteine. J Cell Mol Med 12:1205-1210. doi:10.1111/j.1582-4934.2008.00104.x
15. Herrmann M, Kraenzlin M, Pape G, Sand-Hill M, Herrmann W (2005) Relation between homocysteine and biochemical bone turnover markers and bone mineral density in peri- and post-menopausal women. Clin Chem Lab Med 43:1118-1123. doi:10.1515/CCLM.2005.195 (Pubitemid 41581971)
16. Claes L, Schmalenbach J, Herrmann M, Olku I, Garcia P, Histing T, Obeid R, Schorr H, Herrmann W, Pohlemann T, Menger MD, Holstein JH (2009) Hyperhomocysteinemia is associated with impaired fracture healing in mice. Calcif Tissue Int 85:17-21. doi:10.1007/s00223-009-9262-6
17. Tyagi N, Kandel M, Munjal C, Qipshidze N, Vacek JC, Pushpakumar SB, Metreveli N, Tyagi SC (2011) Homocysteine mediated decrease in bone blood flow and remodeling: role of folic acid. J Orthop Res 29:1511-1516. doi:10.1002/jor.21415
18. Vijayan V, Khandelwal M, Manglani K, Singh RR, Gupta S, Surolia A (2013) Homocysteine alters the osteoprotegerin/RANKL system in the osteoblast to promote bone loss: pivotal role of the redox regulator forkhead O1. Free Radic Biol Med 61C:72-84. doi:10.1016/j.freeradbiomed.2013.03.004
19. Sato Y, Honda Y, Iwamoto J, Kanoko T, Satoh K (2005) Effect of folate and mecobalamin on hip fractures in patients with stroke: a randomized controlled trial. JAMA 293:1082-1088. doi:10.1001/jama.293.9.1082 (Pubitemid 40300282)
20. Cai B, Li X, Wang Y, Liu Y, Yang F, Chen H, Yin K, Tan X, Zhu J, Pan Z, Wang B, Lu Y (2013) Apoptosis of bone marrow mesenchymal stem cells caused by homocysteine via activating JNK signal. PLoS ONE 8:63561. doi:10.1371/journal. pone.0063561
21. Saito M, Marumo K, Soshi S, Kida Y, Ushiku C, Shinohara A (2010) Raloxifene ameliorates detrimental enzymatic and non-enzymatic collagen cross-links and bone strength in rabbits with hyperhomocysteinemia. Osteoporos Int 21:655-666. doi:10.1007/s00198-009-0980-4
22. Lubec B, Fang-Kircher S, Lubec T, Blom HJ, Boers GH (1996) Evidence for McKusick's hypothesis of deficient collagen crosslinking in patients with homocystinuria. Biochim Biophys Acta 1315:159-162 (Pubitemid 26128323)
23. Thaler R, Zwerina J, Rumpler M, Spitzer S, Gamsjaeger S, Paschalis EP, Klaushofer K, Varga F (2013) Homocysteine induces serum amyloid A3 in osteoblasts via unlocking RGD-motifs in collagen. FASEB J 27:446-463. doi:10.1096/fj.12-208058
24. Park SJ, Kim KJ, Kim WU, Oh IH, Cho CS (2012) Involvement of endoplasmic reticulum stress in homocysteine-induced apoptosis of osteoblastic cells. J Bone Miner Metab 30:474-484. doi:10.1007/s00774-011-0346-9
25. Dhonukshe-Rutten RA, Pluijm SM, de Groot LC, Lips P, Smit JH, van Staveren WA (2005) Homocysteine and vitamin B12 status relate to bone turnover markers, broadband ultrasound attenuation, and fractures in healthy elderly people. J Bone Miner Res 20:921-929. doi:10.1359/JBMR.050202 (Pubitemid 40712815)
26. Gjesdal CG, Vollset SE, Ueland PM, Refsum H, Drevon CA, Gjessing HK, Tell GS (2006) Plasma total homocysteine level and bone mineral density: the Hordaland Homocysteine Study. Arch Intern Med 166:88-94. doi:10.1001/archinte. 166.1.88 (Pubitemid 43063846)
27. Gjesdal CG, Vollset SE, Ueland PM, Refsum H, Meyer HE, Tell GS (2007) Plasma homocysteine, folate, and vitamin B 12 and the risk of hip fracture: the Hordaland Homocysteine Study. J Bone Miner Res 22:747-756. doi:10.1359/jbmr. 070210 (Pubitemid 351339104)
28. McLean RR, Jacques PF, Selhub J, Tucker KL, Samelson EJ, Broe KE, Hannan MT, Cupples LA, Kiel DP (2004) Homocysteine as a predictive factor for hip fracture in older persons. N Engl J Med 350:2042-2049. doi:10.1056/NEJMoa032739 (Pubitemid 38596555)
29. Perier MA, Gineyts E, Munoz F, Sornay-Rendu E, Delmas PD (2007) Homocysteine and fracture risk in postmenopausal women: the OFELY study. Osteoporos Int 18:1329-1336. doi:10.1007/s00198-007-0393-1 (Pubitemid 47389468)
30. Gerdhem P, Ivaska KK, Isaksson A, Pettersson K, Vaananen HK, Obrant KJ, Akesson K (2007) Associations between homocysteine, bone turnover, BMD, mortality, and fracture risk in elderly women. J Bone Miner Res 22:127-134. doi:10.1359/jbmr.061003 (Pubitemid 46032605)
31. Kim DJ, Park BL, Koh JM, Kim GS, Kim LH, Cheong HS, Shin HD, Hong JM, Kim TH, Shin HI, Park EK, Kim SY (2006) Methionine synthase reductase polymorphisms are associated with serum osteocalcin levels in postmenopausal women. Exp Mol Med 38:519-524. doi:10.1038/emm.2006.61 (Pubitemid 44704050)
32. Bode MK, Laitinen P, Risteli J, Uusimaa P, Juvonen T (2000) Atherosclerosis, type 1 collagen cross-linking and homocysteine. Atherosclerosis 152:531-532
33. Stanger O, Herrmann W, Pietrzik K, Fowler B, Geisel J, Dierkes J, Weger M (2003) DACH-LIGA homocysteine (German, Austrian and Swiss Homocysteine Society): consensus paper on the rational clinical use of homocysteine, folic acid and B-vitamins in cardiovascular and thrombotic diseases: guidelines and recommendations. Clin Chem Lab Med 41:1392-1403. doi:10.1515/CCLM.2003.214 (Pubitemid 37493551)
34. Tonna EA, Pillsbury N (1959) Changes in the osteoblastic and mitochondrial population of aging periosteum. Nature 183:337-338
35. Meyer MH, Meyer RA Jr (2006) Altered expression of mitochondrial genes in response to fracture in old rats. Acta Orthop 77:944-951. doi:10.1080/ 17453670610013277
36. Adamek G, Felix R, Guenther HL, Fleisch H (1987) Fatty acid oxidation in bone tissue and bone cells in culture. Characterization and hormonal influences. Biochem J 248:129-137
37. Walker DG (1961) Citric acid cycle in osteoblasts and osteoclasts. A histochemical study of normal and parathormone-treated rats. Bull Johns Hopkins Hosp 108:80-99
38. Rosenberg N, Bettman L, Rosenberg O, Soudry M, Gavish M, Bar-Shalom R (2007) Measurement of [(18)F]-fluorodeoxyglucose incorporation into human osteoblast - an experimental method. Cytotechnology 54:1-4. doi:10.1007/s10616- 007-9066-3 (Pubitemid 46944862)
39. Komarova SV, Ataullakhanov FI, Globus RK (2000) Bioenergetics and mitochondrial transmembrane potential during differentiation of cultured osteoblasts. Am J Physiol Cell Physiol 279:C1220-C1229
40. Gerber I, ap GI, Alini M, Wallimann T (2005) Stimulatory effects of creatine on metabolic activity, differentiation and mineralization of primary osteoblast-like cells in monolayer and micromass cell cultures. Eur Cell Mater 10:8-22
41. Hobson GM, Funanage VL, Elsemore J, Yagami M, Rajpurohit R, Perriard JC, Hickok NJ, Shapiro IM, Tuan RS (1999) Developmental expression of creatine kinase isoenzymes in chicken growth cartilage. J Bone Miner Res 14:747-756. doi:10.1359/jbmr.1999.14.5.747 (Pubitemid 29210601)
42. Katoh R, Iyoda K, Oohira A, Kato K, Nogami H (1991) Zonal and age-related difference in the amounts of creatine kinase subunits in cartilage. Clin Orthop Relat Res 271:283-287
43. Hu YY, Rawal A, Schmidt-Rohr K (2010) Strongly bound citrate stabilizes the apatite nanocrystals in bone. Proc Natl Acad Sci USA 107:22425-22429. doi:10.1073/pnas.1009219107
44. Chen RM, Liu HC, Lin YL, Jean WC, Chen JS, Wang JH (2002) Nitric oxide induces osteoblast apoptosis through the de novo synthesis of Bax protein. J Orthop Res 20:295-302. doi:10.1016/S0736-0266(01)00086-9
45. Hay E, Lemonnier J, Fromigue O, Marie PJ (2001) Bone morphogenetic protein-2 promotes osteoblast apoptosis through a Smad-independent, protein kinase C-dependent signaling pathway. J Biol Chem 276:29028-29036. doi:10.1074/jbc.M011265200
46. Ho WP, Chen TL, Chiu WT, Tai YT, Chen RM (2005) Nitric oxide induces osteoblast apoptosis through a mitochondria-dependent pathway. Ann N Y Acad Sci 1042:460-470. doi:10.1196/annals.1338.039
47. Pietila M, Lehtonen S, Narhi M, Hassinen IE, Leskela HV, Aranko K, Nordstrom K, Vepsalainen A, Lehenkari P (2010) Mitochondrial function determines the viability and osteogenic potency of human mesenchymal stem cells. Tissue Eng Part C Methods 16:435-445. doi:10.1089/ten.tec.2009.0247
48. Chen CT, Shih YR, Kuo TK, Lee OK, Wei YH (2008) Coordinated changes of mitochondrial biogenesis and antioxidant enzymes during osteogenic differentiation of human mesenchymal stem cells. Stem Cells 26:960-968. doi:10.1634/stemcells.2007-0509
49. An JH, Yang JY, Ahn BY, Cho SW, Jung JY, Cho HY, Cho YM, Kim SW, Park KS, Kim SY, Lee HK, Shin CS (2010) Enhanced mitochondrial biogenesis contributes to Wnt induced osteoblastic differentiation of C3H10T1/2 cells. Bone 47:140-150. doi:10.1016/j.bone.2010.04.593
50. Nervina JM, Magyar CE, Pirih FQ, Tetradis S (2006) PGC-1alpha is induced by parathyroid hormone and coactivates Nurr1-mediated promoter activity in osteoblasts. Bone 39:1018-1025. doi:10.1016/j.bone.2006.04.023 (Pubitemid 44528369)
51. Noble BS (2008) The osteocyte lineage. Arch Biochem Biophys 473:106-111. doi:10.1016/j.abb.2008.04.009
52. Ishii KA, Fumoto T, Iwai K, Takeshita S, Ito M, Shimohata N, Aburatani H, Taketani S, Lelliott CJ, Vidal-Puig A, Ikeda K (2009) Coordination of PGC-1beta and iron uptake in mitochondrial biogenesis and osteoclast activation. Nat Med 15:259-266. doi:10.1038/nm.1910
53. Kim DJ, Koh JM, Lee O, Kim NJ, Lee YS, Kim YS, Park JY, Lee KU, Kim GS (2006) Homocysteine enhances apoptosis in human bone marrow stromal cells. Bone 39:582-590. doi:10.1016/j.bone.2006.03.004 (Pubitemid 44149276)
54. Vacek TP, Kalani A, Voor MJ, Tyagi SC, Tyagi N (2013) The role of homocysteine in bone remodeling. Clin Chem Lab Med 51:579-590. doi:10.1515/cclm-2012-0605
55. Pasternak B, Aspenberg P (2009) Metalloproteinases and their inhibitors-diagnostic and therapeutic opportunities in orthopedics. Acta Orthop 80:693-703. doi:10.3109/17453670903448257
56. Kalani A, Kamat PK, Givvimani S, Brown K, Metreveli N, Tyagi SC, Tyagi N (2013) Nutri-epigenetics ameliorates bloodbrain barrier damage and neurodegeneration in hyperhomocysteinemia: role of folic acid. J Mol Neurosci. doi:10.1007/s12031-013-0122-5
57. Bui C, Barter MJ, Scott JL, Xu Y, Galler M, Reynard LN, Rowan AD, Young DA (2012) cAMP response element-binding (CREB) recruitment following a specific CpG demethylation leads to the elevated expression of the matrix metalloproteinase 13 in human articular chondrocytes and osteoarthritis. FASEB J 26:3000-3011. doi:10.1096/fj.12-206367
58. Hashimoto K, Otero M, Imagawa K, de Andres MC, Coico JM, Roach HI, Oreffo RO, Marcu KB, Goldring MB (2013) Regulated transcription of human matrix metalloproteinase 13 (MMP13) and interleukin-1beta (IL1B) genes in chondrocytes depends on methylation of specific proximal promoter CpG sites. J Biol Chem 288:10061-10072. doi:10.1074/jbc.M112.421156
59. de Andres MC, Imagawa K, Hashimoto K, Gonzalez A, Roach HI, Goldring MB, Oreffo RO (2013) Loss of methylation in CpG sites in the NF-kappaB enhancer elements of inducible nitric oxide synthase is responsible for gene induction in human articular chondrocytes. Arthritis Rheum 65:732-742. doi:10.1002/art.37806
60. Nakano K, Whitaker JW, Boyle DL, Wang W, Firestein GS (2013) DNA methylome signature in rheumatoid arthritis. Ann Rheum Dis 72:110-117. doi:10.1136/annrheumdis-2012-201526
61. Takami N, Osawa K, Miura Y, Komai K, Taniguchi M, Shiraishi M, Sato K, Iguchi T, Shiozawa K, Hashiramoto A, Shiozawa S (2006) Hypermethylated promoter region of DR3, the death receptor 3 gene, in rheumatoid arthritis synovial cells. Arthritis Rheum 54:779-787. doi:10.1002/art.21637
62. Ishida K, Kobayashi T, Ito S, Komatsu Y, Yokoyama T, Okada M, Abe A, Murasawa A, YoshieH(2012) Interleukin-6 gene promoter methylation in rheumatoid arthritis and chronic periodontitis. J Periodontol 83:917-925. doi:10.1902/jop.2011.110356
63. Nile CJ, Read RC, Akil M, Duff GW, Wilson AG (2008) Methylation status of a single CpG site in the IL6 promoter is related to IL6 messenger RNA levels and rheumatoid arthritis. Arthritis Rheum 58:2686-2693. doi:10.1002/art.23758
64. Fu LH, Ma CL, Cong B, Li SJ, Chen HY, Zhang JG (2011) Hypomethylation of proximal CpG motif of interleukin-10 promoter regulates its expression in human rheumatoid arthritis. Acta Pharmacol Sin 32:1373-1380. doi:10.1038/aps.2011.98
65. Lin SY, Hsieh SC, Lin YC, Lee CN, Tsai MH, Lai LC, Chuang EY, Chen PC, Hung CC, Chen LY, Hsieh WS, Niu DM, Su YN, Ho HN (2012) A whole genome methylation analysis of systemic lupus erythematosus: hypomethylation of the IL10 and IL1R2 promoters is associated with disease activity. Genes Immun 13:214-220. doi:10.1038/gene.2011.74
66. Karouzakis E, Rengel Y, Jungel A, Kolling C, Gay RE, Michel BA, Tak PP, Gay S, Neidhart M, Ospelt C (2011) DNA methylation regulates the expression of CXCL12 in rheumatoid arthritis synovial fibroblasts. Genes Immun 12:643-652. doi:10.1038/gene.2011.45
67. Chabchoub G, Uz E, Maalej A, Mustafa CA, Rebai A, Mnif M, Bahloul Z, Farid NR, Ozcelik T, Ayadi H (2009) Analysis of skewed X-chromosome inactivation in females with rheumatoid arthritis and autoimmune thyroid diseases. Arthritis Res Ther 11:R106. doi:10.1186/ar2759
68. Jeffries MA, Dozmorov M, Tang Y, Merrill JT, Wren JD, Sawalha AH (2011) Genome-wide DNA methylation patterns in CD4+ T cells from patients with systemic lupus erythematosus. Epigenetics 6:593-601
69. Furukawa H, Oka S, Matsui T, Hashimoto A, Arinuma Y, Komiya A, Fukui N, Tsuchiya N, Tohma S (2013) Genome, epigenome and transcriptome analyses of a pair of monozygotic twins discordant for systemic lupus erythematosus. Hum Immunol 74:170-175. doi:10.1016/j.humimm.2012.11.007
70. Kalani A, Kamat PK, Tyagi SC, Tyagi N (2013) Synergy of homocysteine, MicroRNA, and epigenetics: a novel therapeutic approach for stroke. Mol Neurobiol 48:157-168. doi:10.1007/s12035-013-8421-y
71. Balasubramanian S, Verner E, Buggy JJ (2009) Isoform-specific histone deacetylase inhibitors: the next step? Cancer Lett 280:211-221. doi:10.1016/j.canlet.2009.02.013
72. Khan N, Jeffers M, Kumar S, Hackett C, Boldog F, Khramtsov N, Qian X, Mills E, Berghs SC, Carey N, Finn PW, Collins LS, Tumber A, Ritchie JW, Jensen PB, Lichenstein HS, Sehested M (2008) Determination of the class and isoform selectivity of small-molecule histone deacetylase inhibitors. Biochem J 409:581-589. doi:10.1042/BJ20070779 (Pubitemid 351184977)
73. Zhang Y, Xie RL, Croce CM, Stein JL, Lian JB, van Wijnen AJ, Stein GS (2011) A program of microRNAs controls osteogenic lineage progression by targeting transcription factor Runx2. Proc Natl Acad Sci USA 108:9863-9868. doi:10.1073/pnas.1018493108
74. Hassan MQ, Gordon JA, Beloti MM, Croce CM, van Wijnen AJ, Stein JL, Stein GS, Lian JB (2010) A network connecting Runx2, SATB2, and the miR-23a∼ 27a∼ 24-2 cluster regulates the osteoblast differentiation program. Proc Natl Acad Sci USA 107:19879-19884. doi:10.1073/pnas.1007698107
75. Kim EJ, Kang IH, Lee JW, Jang WG, Koh JT (2013) MiR-433 mediates ERRgamma-suppressed osteoblast differentiation via direct targeting to Runx2 mRNA in C3H10T1/2 cells. Life Sci 92:562-568. doi:10.1016/j.lfs.2013.01.015
76. Wu T, Zhou H, Hong Y, Li J, Jiang X, Huang H (2012) miR-30 family members negatively regulate osteoblast differentiation. J Biol Chem 287:7503-7511. doi:10.1074/jbc.M111.292722
77. Sugatani T, Vacher J, Hruska KA (2011) A microRNA expression signature of osteoclastogenesis. Blood 117:3648-3657. doi:10.1182/blood-2010-10-311415
78. Mann M, Barad O, Agami R, Geiger B, Hornstein E (2010) miRNA-based mechanism for the commitment of multipotent progenitors to a single cellular fate. Proc Natl Acad Sci USA 107:15804-15809. doi:10.1073/pnas.0915022107
79. Nass MM (1973) Differential methylation of mitochondrial and nuclear DNA in cultured mouse, hamster and virus-transformed hamster cells. In vivo and in vitromethylation. JMol Biol 80:155-175
80. Shmookler Reis RJ, Goldstein S (1983) Mitochondrial DNA in mortal and immortal human cells. Genome number, integrity, and methylation. J Biol Chem 258:9078-9085 (Pubitemid 13035574)
81. Mushkambarov NN, Votrin II, Debov SS (1976) Methylation of endogenous DNA in isolated rat liver nuclei and mitochondria. Vopr Med Khim 22:659-664
82. Kudriashova IB, Kirnos MD, Vaniushin BF (1976) DNA-methylase activities from animal mitochondria and nuclei: different specificity of DNA methylation. Biokhimiia 41:1968-1977
83. Iacobazzi V, Castegna A, Infantino V, Andria G (2013) Mitochondrial DNA methylation as a next-generation biomarker and diagnostic tool. Mol Genet Metab 110:25-34. doi:10.1016/j.ymgme.2013.07.012
84. Chen Z, Li Y, Zhang H, Huang P, Luthra R (2010) Hypoxia-regulated microRNA-210 modulates mitochondrial function and decreases ISCU and COX10 expression. Oncogene 29:4362-4368. doi:10.1038/onc.2010.193
85. Kren BT, Wong PY, Sarver A, Zhang X, Zeng Y, Steer CJ (2009) MicroRNAs identified in highly purified liver-derived mitochondria may play a role in apoptosis. RNA Biol 6:65-72